Research report of Chinese Acarbose market(API and Preparation) (2008 Edition)
(we keep updating the report with new information) Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Format: Hardcopy and Adobe PDF
Price: US$2,100
Contact: Mr. Bian chenghua Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101 Fax: 86-10-68052505
E-mail: bianch@healthoo.com wuhf@healthoo.com
Brief introduction
Acarbose is a pseudo-tetrasaccharide produced by biosynthesis, the
first drug in the class called alpha-glucosidase inhibitors, aslo the
first alpha-glucosidase inhibitor approved by US FDA, developed by
Bayer AG。Acarbose was marketed in Germany firstly in July 1984, brand
name Glucobay. Acarbose is the top 1 seller in the oral antidiabetic
market in China.
The report represents the import and export status of
Acarbose API, production status of Acarbose API in China, sales
analysis of Acarbose preparations in China, and the suggestions for
marketing. In the report you can know the global output and market
size of Acarbose API, market sizes of Acarbose API and preparations
in China, the prices, the key manufacturers. The table of contents
Overview of Acarbose market in China and the global marekt
1 Manufacturers of Acarbose API(Bulk drug)
1.1 Bayer AG
1.2 CKD Bio Corporation
1.3 Chinese enterprises
1.3.1 Sichuan Industrial Institute of Antibiotics Co. Ltd.
(SIIA Co.Ltd.)
1.3.2 Hangzhou Huadong Medicine Group Co.,Ltd
1.3.3 Zhejiang Zhebei Pharmaceutical Co.,Ltd.
1.3.4 Zhejiang Hisun Pharmaceutical CO., Ltd
1.3.5 New manufacturers
2 Import and export situation of Acarbose API
2.1 Total export amount
2.2 Export volumes of different enterprises
2.2.1 Hangzhou Huadong Medicine Group Co.,Ltd
2.2.2 Zhejiang Hisun Pharmaceutical CO., Ltd
2.3 Import statistic 3 Sales analysis of Acarbose preparations in sample hospitals
3.1 Market scale and market shares of different drugs in Chinese
market of drugs for regulating blood sugar
3.2 Market shares and growth trend of Acarbose preparations of
different enterprises from 2003 to 2007
3.2.1 Bayer AG
3.2.2 Hangzhou Huadong Medicine Group Co.,Ltd
3.2.3 Sichuan Baoguang Pharmaceutical Technology Co., LTD
3.3 Sales analysis in sample cities
3.4 Analysis of other competition breeds
3.4.1 Voglibose
3.4.2 Repaglinide
4 Suggestions for marketing |
